Back to Search
Start Over
Metabolomic Profiling and Drug Interaction CharacterizationReveal Riboflavin as aBreast Cancer Resistance Protein-Specific Endogenous Biomarkerthat DemonstratesPrediction of Transporter Activity In Vivo
- Source :
- Drug Metabolism and Disposition. :DMD-AR
- Publication Year :
- 2023
- Publisher :
- American Society for Pharmacology & Experimental Therapeutics (ASPET), 2023.
- Subjects :
- Pharmacology
Pharmaceutical Science
Subjects
Details
- ISSN :
- 1521009X and 00909556
- Database :
- OpenAIRE
- Journal :
- Drug Metabolism and Disposition
- Accession number :
- edsair.doi...........682701f0e5a98a5ec8e72d44c0aad89e
- Full Text :
- https://doi.org/10.1124/dmd.123.001284